Pacific Biosciences of California PACB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $12.47M-15.5% | $14.76M-8.1% | $16.05M-19.5% | $19.95M-6.4% | $21.32M-10.4% | ||
| —— | —— | —— | —— | —— | ||
| -$128.58M+76.5% | -$546.38M-8.0% | -$506.01M+4.3% | -$528.73M+19.9% | -$660.12M-111% | ||
| $110K-97.4% | $4.18M+0.3% | $4.17M+1.8% | $4.09M-19.2% | $5.07M+408% | ||
| $3.33M-99.1% | $364.54M-1.0% | $368.34M-0.8% | $371.15M-0.9% | $374.54M+1,980% | ||
| —— | —— | —— | —— | —— | ||
| $4.08M-98.9% | $369.45M-1.6% | $375.28M-1.5% | $381.12M-1.5% | $386.95M+1,312% | ||
| $0+100% | -$18.7M+9.4% | -$20.65M-6.0% | -$19.48M0.0% | -$19.48M-2,192% | ||
| $10.06M-22.6% | $12.99M-0.8% | $13.09M-11.7% | $14.83M-5.4% | $15.67M+13.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | $0-100% | $38.6M-50.0% | $77.2M-33.3% | $115.81M-25.0% | ||
| $0-100% | $15M— | —— | —— | —— | ||
| -$315K-113% | $2.48M-43.4% | $4.39M+276% | -$2.49M— | —— | ||
| —— | —— | —— | -$176K— | —— | ||
| $3.16M+0.1% | $3.16M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$2.8M+67.1% | -$8.51M— | —— | —— | —— | ||
| —— | $8.26M-16.5% | $9.9M-14.2% | $11.53M-12.4% | $13.17M-11.0% | ||
| —— | —— | —— | —— | -$47.58M-10.7% | ||
| $106.07M-8.1% | $115.45M-21.8% | $147.66M-2.7% | $151.82M-25.3% | $203.37M+64.0% | ||
| -$111.84M-0.6% | -$111.21M+9.4% | -$122.79M+17.9% | -$149.55M+14.3% | -$174.43M+15.3% | ||
| —— | —— | —— | —— | $5M— | ||
| $207.54M-4.3% | $216.91M-17.9% | $264.29M-15.6% | $313.06M-15.1% | $368.55M-26.1% | ||
| $4.45M+59.1% | $2.8M-21.3% | $3.56M— | —— | —— | ||
| $274.88M-19.2% | $340.07M-13.6% | $393.62M-10.1% | $437.8M-19.8% | $545.76M-8.1% | ||
| $36.93M-11.4% | $41.67M-13.4% | $48.11M-13.1% | $55.39M-8.8% | $60.71M-14.5% | ||
| -$119.15M+30.5% | -$171.43M+38.2% | -$277.32M+6.0% | -$294.95M+29.7% | -$419.27M+3.2% | ||
| -$133.28M+75.9% | -$553.86M+16.8% | -$665.69M+3.6% | -$690.89M+15.9% | -$821.89M-73.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pacific Biosciences of California's revenue?
- Pacific Biosciences of California (PACB) generated $160.0M in revenue over the trailing twelve months, up 5.0% year over year.
- Is Pacific Biosciences of California profitable?
- Pacific Biosciences of California is not currently profitable: it reported a net loss of $128.6M over the trailing twelve months, a -80.3% net margin.
- What are Pacific Biosciences of California's profit margins?
- Gross margin is 37.5% and operating margin is -83.3%, with a -80.3% net margin.
- What is Pacific Biosciences of California's earnings per share?
- Pacific Biosciences of California's diluted EPS over the trailing twelve months is $-0.43.
- Where does Pacific Biosciences of California's income statement data come from?
- Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
